FNY Investment Advisers »

Aziyo Biologics shares owned by FNY Investment Advisers

Quarter-by-quarter ownership of Aziyo Biologics (ELUT) shares owned by FNY Investment Advisers from 13F filings

Historical chart of FNY Investment Advisers investment in Aziyo Biologics

Tip: Access up to 7 years of quarterly data

All positions including Aziyo Biologics held by FNY Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aziyo Biologics by FNY Investment Advisers

Quarter filed Position value Share count Share price at filing
2025-12-31 $25k 37k 0.68

More positions owned by FNY Investment Advisers

Cidara Therapeutics (CDTX)
Bank Of Montreal Cadcom (BMO)
Amplify Etf Tr (SILJ)
UnitedHealth (UNH)
Global X Fds global x copper (COPX)
Monolithic Power Systems (MPWR)
Morgan Stanley (MS)
Codere Online Luxembourg Ord (CDRO)
NVIDIA Corporation (NVDA)
Vaneck Vectors Gold Miners mutual (GDX)
Philip Morris International (PM)
Bleichroeder Acquisition Cor (BACQ)
Deere & Company (DE)
Futurecrest Acquisition Corp
Norfolk Southern (NSC)

View all positions for FNY Investment Advisers

Top funds holding Aziyo Biologics

Nantahala Capital Management
AIGH Capital Management
Silverarc Capital Management
Alyeska Investment Group
Deerfield Management Company
Vanguard Group
Knollwood Investment Advisory
Perkins Capital Management
Birchview Capital
Geode Capital Management
BlackRock
Jane Street
Renaissance Technologies
Citadel Advisors
Rossmore Private Capital

View all funds holding Aziyo Biologics